Amazon eyeing investment in Indian pharmacy chain

Amy Baxter | | Health Exec | Policy & Regulations
Amazon logo

Photo by Anna Shvets via Pexels

Retail giant Amazon is in early talks to invest in Medplus, India’s second-largest pharmacy chain, according to FactorDaily. The two companies are only in preliminary discussions—and it is “too early to call it a deal,” sources told FactorDaily.

Medplus was founded in 2006 and runs more than 1,400 across 12 Indian states.

A potential investment in a pharmacy benefits manager like Medplus should come as no surprise. Amazon has made increasingly larger moves into the healthcare space, including launching its own line of over-the-counter medicines and teaming up with JPMorgan and Berkshire Hathaway to form a new healthcare venture.

Amazon also recently acquired online pharmacy PillPack for about $1 billion.

See the full report here:

Amazon in talks to buy Medplus, India’s No. 2 pharmacy chain

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

HHS employees offered two months of pay to quit their jobs
To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
CMS ends ACA special enrollment, changes deadline for signing up
Report: NIH continues to pull research grants, in violation of court orders
HHS sends 80K workers a $25K ‘voluntary’ resignation notice
More than 1,000 hospitals earn $700M opioid crisis judgment

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.